Hsa_circ_0079875 functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clinicians. 2021;71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi: 10.3322/caac.21492
   PubMed Web of Science ®Google Scholar
• Anwanwan D, Singh SK, Singh S, et al. Challenges in liver cancer and possible treatment approaches. Biochim Biophys Acta (BBA)- Rev Cancer. 2020;1873(1):188314. doi: 10.1016/j.bbcan.2019.188314
   PubMed Web of Science ®Google Scholar
• Stotz M, Gerger A, Haybaeck J, et al. Molecular targeted therapies in hepatocellular carcinoma: past, present and Future. Anticancer Res. 2015;35(11):5737–5744.
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Nault JC. Advances in molecular classification and precision oncology in hepatocellular carcinoma. J Hepatol. 2020;72(2):215–229. doi: 10.1016/j.jhep.2019.08.017
   PubMed Web of Science ®Google Scholar
• Greten TF, Lai CW, Li G, et al. Targeted and immune-based therapies for hepatocellular carcinoma. Gastroenterology. 2019;156(2):510–524. doi: 10.1053/j.gastro.2018.09.051
   PubMed Web of Science ®Google Scholar
• Bekric D, Ocker M, Mayr C, et al. Ferroptosis in hepatocellular carcinoma: mechanisms, drug targets and approaches to clinical translation. Cancers (Basel). 2022;14(7):1826. doi: 10.3390/cancers14071826
   PubMed Web of Science ®Google Scholar
• Bao MH, Wong CC. Hypoxia, metabolic reprogramming, and drug resistance in liver cancer. Cells. 2021;10(7):1715. doi: 10.3390/cells10071715
   PubMed Web of Science ®Google Scholar
• Yu YZ, Lv DJ, Wang C, et al. Hsa_circ_0003258 promotes prostate cancer metastasis by complexing with IGF2BP3 and sponging miR-653-5p. Mol Cancer. 2022;21(1):12. doi: 10.1186/s12943-021-01480-x
   PubMed Web of Science ®Google Scholar
• Luo X, Liu Y, Li H, et al. Hsa_circ_0013290 acts as cancer-promoting gene in hepatocellular Carcinoma. Cancer Control. 2021;28:10732748211055681. doi: 10.1177/10732748211055681
   Web of Science ®Google Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227. doi: 10.1016/j.jhep.2018.01.012
   PubMed Web of Science ®Google Scholar
• Deng F, Xu Z, Zhou J, et al. ANLN regulated by miR-30a-5p mediates malignant progression of lung adenocarcinoma. Comput Math Meth Med. 2021;2021:1–12. doi: 10.1155/2021/9549287
   Web of Science ®Google Scholar
• Wang B, Zhang XL, Li CX, et al. ANLN promotes carcinogenesis in oral cancer by regulating the PI3K/mTOR signaling pathway. Head Face Med. 2021;17(1):18. doi: 10.1186/s13005-021-00269-z
   PubMed Web of Science ®Google Scholar
• Wang Z, Hu S, Li X, et al. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN. BMC Cancer. 2021;21(1):1188. doi: 10.1186/s12885-021-08914-1
   PubMed Web of Science ®Google Scholar
• Chen S, Gao Y, Chen F, et al. ANLN serves as an oncogene in bladder urothelial carcinoma via activating JNK Signaling Pathway. Urol Int. 2023;2022(3):1–11. doi: 10.1159/000524204
   Google Scholar
• Liu Y, Cao P, Cao F, et al. ANLN, regulated by SP2, promotes colorectal carcinoma cell proliferation via PI3K/AKT and MAPK signaling pathway. J Invest Surg. 2022;35(2):268–277. doi: 10.1080/08941939.2020.1850939
   PubMed Web of Science ®Google Scholar
• Chen J, Li Z, Jia X, et al. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity. Oncogene. 2022;41(22):3118–3130. doi: 10.1038/s41388-022-02274-1
   PubMed Web of Science ®Google Scholar
• Shi Y, Ma X, Wang M, et al. Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers. Cancer Cell Int. 2022;22(1):188. doi: 10.1186/s12935-022-02610-1
   PubMed Web of Science ®Google Scholar
• Zhang T, Jing B, Bai Y, et al. Circular RNA circTMEM45A acts as the sponge of MicroRNA-665 to promote hepatocellular carcinoma progression. Mol Ther Nucleic Acids. 2020;22:285–297. doi: 10.1016/j.omtn.2020.08.011
   PubMedGoogle Scholar
• Hu Y, Yang C, Yang S, et al. miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB. Cell Death Dis. 2018;9(10):954. doi: 10.1038/s41419-018-0978-y
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov. 2013;3(10):1113–1121. doi: 10.1158/2159-8290.CD-13-0202
   PubMed Web of Science ®Google Scholar
• Xu H, Wang C, Song H, et al. RNA-Seq profiling of circular RNAs in human colorectal cancer liver metastasis and the potential biomarkers. Mol Cancer. 2019;18(1):8. doi: 10.1186/s12943-018-0932-8
   PubMedGoogle Scholar
• Zhang DD, Shi Y, Liu JB, et al. Construction of a Myc-associated ceRNA network reveals a prognostic signature in hepatocellular carcinoma. Mol Ther - Nucleic Acids. 2021;24:1033–1050. doi: 10.1016/j.omtn.2021.04.019
   Google Scholar
• Shi Y, Liu JB, Deng J, et al. The role of ceRNA-mediated diagnosis and therapy in hepatocellular carcinoma. Hereditas. 2021;158(1):44. doi: 10.1186/s41065-021-00208-7
   PubMed Web of Science ®Google Scholar
• Zhao L, Hu K, Cao J, et al. lncRNA miat functions as a ceRNA to up-regulate sirt1 by sponging miR-22-3p in HCC cellular senescence. Aging (Albany NY). 2019;11(17):7098–7122. doi: 10.18632/aging.102240
   PubMedGoogle Scholar
• Chen L, Shan G. CircRNA in cancer: Fundamental mechanism and clinical potential [J]. Cancer Lett. 2021;505:49–57. doi: 10.1016/j.canlet.2021.02.004
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi: 10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Huang G, Liang M, Liu H, et al. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway. Cell Death Dis. 2020;11(12):1065. doi: 10.1038/s41419-020-03276-1
   PubMed Web of Science ®Google Scholar
• Han K, Wang FW, C H C, et al. CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17. Mol Cancer. 2020;19(1):60. doi: 10.1186/s12943-020-01184-8
   PubMed Web of Science ®Google Scholar
• Shi Y, Fang N, Li Y, et al. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis. Cancer Sci. 2020;111(8):2824–2836. doi: 10.1111/cas.14511
   PubMed Web of Science ®Google Scholar
• Chen X, Mao R, Su W, et al. Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer [J]. Autophagy. 2020;16(4):659–671. doi: 10.1080/15548627.2019.1634945
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen Z, Sun J, et al. CircRNA hsa_circRNA_0000069 promotes the proliferation, migration and invasion of cervical cancer through miR-873-5p/TUSC3 axis. Cancer Cell Int. 2020;20(1):287. doi: 10.1186/s12935-020-01387-5
   PubMedGoogle Scholar
• Liu K, Cui L, Li C, et al. Pan-cancer analysis of the prognostic and immunological role of ANLN: An onco-immunological biomarker. Front Genet. 2022;13:922472. doi: 10.3389/fgene.2022.922472
   PubMedGoogle Scholar
• Tuan NM, Lee CH. Role of anillin in tumour: from a prognostic biomarker to a novel target. Cancers (Basel). 2020;12(6):1600. doi: 10.3390/cancers12061600
   PubMed Web of Science ®Google Scholar
• Li L, Huang K, Zhao H, et al. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma. Cell Cycle. 2020;19(10):1236–1252. doi: 10.1080/15384101.2020.1749471
   PubMed Web of Science ®Google Scholar